Healthcare Services Group (HCSG) Financials

$14.78 +0.11 (+0.75%)

Closing price 05/20/2025 04:00 PM Eastern

Extended Trading

$14.82 +0.04 (+0.24%)

As of 08:44 AM Eastern

Annual Income Statements for Healthcare Services Group

This table shows Healthcare Services Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Net Income / (Loss) Attributable to Common Shareholders	39	40	27	47	99	65	84	88
Consolidated Net Income / (Loss)	39	38	34	49	99	65	84	88
Net Income / (Loss) Continuing Operations	39	38	34	49	99	65	84	88
Total Pre-Tax Income	53	53	45	66	129	85	100	133
Total Operating Income	45	48	53	57	117	78	98	124
Total Gross Profit	228	215	193	231	268	228	234	251
Total Revenue	1,716	1,671	1,690	1,642	1,760	1,841	2,003	1,861
Operating Revenue	1,716	1,671	1,690	1,642	1,760	1,841	2,003	1,861
Total Cost of Revenue	1,488	1,457	1,497	1,411	1,492	1,613	1,768	1,611
Operating Cost of Revenue	1,488	1,457	1,497	1,411	1,492	1,613	1,768	1,611
Total Operating Expenses	183	167	140	173	151	150	137	127
Selling, General & Admin Expense	183	167	140	173	151	150	137	127
Total Other Income / (Expense), net	7.91	5.08	-8.41	8.05	12	7.22	2.07	9.08
Interest & Investment Income	7.91	5.08	-8.41	8.05	12	7.22	2.07	10
Income Tax Expense	13	15	10	17	31	21	16	45
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	0.47	-1.63	7.48	1.56	-	-	-	-
Basic Earnings per Share	$0.54	$0.52	$0.46	$0.65	$1.32	$0.87	$1.13	$1.20
Weighted Average Basic Shares Outstanding	73.75M	74.29M	74.34M	74.82M	74.70M	74.36M	74.00M	73.36M
Diluted Earnings per Share	$0.53	$0.52	$0.46	$0.65	$1.32	$0.87	$1.12	$1.19
Weighted Average Diluted Shares Outstanding	73.99M	74.34M	74.35M	74.96M	74.79M	74.59M	74.61M	74.35M
Weighted Average Basic & Diluted Shares Outstanding	73.49M	73.58M	74.39M	74.00M	74.72M	74.40M	73.90M	73.50M

This table shows Healthcare Services Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	18	10	16	-2.23	15	26	-6.69	7.39	13	11	-1.97
Consolidated Net Income / (Loss)	17	12	14	-1.79	15	24	-5.05	8.25	12	16	0.32
Net Income / (Loss) Continuing Operations	17	12	14	-1.79	15	24	-5.05	8.25	12	16	0.32
Total Pre-Tax Income	24	15	19	-1.99	21	32	-6.33	11	16	20	0.99
Total Operating Income	23	14	17	-2.89	18	28	-4.60	9.30	15	17	1.79
Total Gross Profit	68	59	63	42	65	75	34	51	55	57	38
Total Revenue	448	438	428	426	423	424	411	419	417	424	414
Operating Revenue	448	438	428	426	423	424	411	419	417	424	414
Total Cost of Revenue	380	379	365	385	359	349	377	368	362	367	377
Operating Cost of Revenue	380	379	365	385	359	349	377	368	362	367	377
Total Operating Expenses	45	45	47	44	47	46	39	41	40	40	36
Selling, General & Admin Expense	45	45	47	44	47	46	39	41	40	40	36
Total Other Income / (Expense), net	0.89	1.03	2.28	0.91	3.70	3.83	-1.74	1.64	1.35	2.37	-0.80
Interest & Investment Income	0.89	1.03	2.28	0.91	3.70	3.83	-1.74	1.64	1.35	2.37	-0.80
Income Tax Expense	6.67	2.89	4.78	-0.20	6.01	8.79	-1.29	2.68	4.48	3.76	0.67
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-0.50	1.79	-2.09	0.45	0.33	-2.93	1.65	0.86	-1.21	-	2.29
Basic Earnings per Share	$0.23	$0.16	$0.19	($0.02)	$0.21	$0.32	($0.07)	$0.11	$0.16	$0.22	$0.00
Weighted Average Basic Shares Outstanding	73.67M	73.75M	73.69M	73.85M	73.93M	74.29M	74.36M	74.48M	74.50M	74.34M	74.34M
Diluted Earnings per Share	$0.23	$0.15	$0.19	($0.02)	$0.21	$0.32	($0.07)	$0.11	$0.16	$0.22	$0.00
Weighted Average Diluted Shares Outstanding	73.96M	73.99M	73.93M	73.85M	74.06M	74.34M	74.36M	74.57M	74.52M	74.35M	74.35M
Weighted Average Basic & Diluted Shares Outstanding	72.92M	73.49M	73.29M	73.38M	73.65M	73.58M	73.85M	74.20M	74.20M	74.39M	74.09M

This table details how cash moves in and out of Healthcare Services Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Net Change in Cash & Equivalents	5.80	28	-45	-69	112	1.30	16	-14
Net Cash From Operating Activities	31	43	-8.17	37	217	94	80	7.63
Net Cash From Continuing Operating Activities	31	43	-8.17	37	217	94	80	7.63
Net Income / (Loss) Continuing Operations	39	38	34	49	99	65	84	88
Consolidated Net Income / (Loss)	39	38	34	49	99	65	84	88
Depreciation Expense	15	14	15	15	14	14	9.27	8.89
Amortization Expense	1.50	2.14	2.22	2.28	1.82	1.43	1.37	1.30
Non-Cash Adjustments To Reconcile Net Income	49	39	52	14	9.45	25	59	12
Changes in Operating Assets and Liabilities, net	-74	-50	-112	-43	93	-11	-73	-103
Net Cash From Investing Activities	6.05	-3.29	2.58	-23	-37	-16	-9.59	-15
Net Cash From Continuing Investing Activities	6.05	-3.29	2.58	-23	-37	-16	-9.59	-15
Purchase of Property, Plant & Equipment	-6.34	-5.41	-5.21	-5.69	-4.34	-4.37	-4.94	-5.40
Acquisitions	-2.75	0.00	-0.11	-24	0.00	0.00	-	-4.58
Purchase of Investments	-52	0.00	-2.88	-20	-39	-34	-14	-34
Sale of Property, Plant & Equipment	0.21	0.12	0.39	0.21	0.27	0.20	0.64	0.34
Sale and/or Maturity of Investments	67	1.99	10	27	6.27	21	9.01	29
Net Cash From Financing Activities	-31	-12	-39	-83	-68	-76	-54	-6.96
Net Cash From Continuing Financing Activities	-31	-12	-39	-83	-68	-76	-54	-6.96
Repayment of Debt	-25	0.00	25	0.00	-10	-20	-5.38	-
Repurchase of Common Equity	-6.05	-12	-1.07	-23	-0.68	-0.59	-0.28	-
Payment of Dividends	0.00	0.00	-63	-62	-61	-59	-57	-55
Issuance of Common Equity	0.00	0.00	0.11	0.09	0.09	0.09	0.09	0.10
Other Financing Activities, net	0.00	0.00	0.41	2.43	2.92	3.63	8.80	13
Cash Interest Paid	6.49	7.81	2.82	1.39	1.37	3.46	3.09	1.36
Cash Income Taxes Paid	15	5.59	3.31	21	45	20	38	35

This table details how cash moves in and out of Healthcare Services Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	4.25	32	-1.41	-24	-0.35	23	2.65	13	-10	6.65	-12
Net Cash From Operating Activities	28	36	4.31	16	-26	49	2.94	7.40	-16	23	-9.90
Net Cash From Continuing Operating Activities	28	36	4.31	16	-26	49	2.94	7.40	-16	23	-9.90
Net Income / (Loss) Continuing Operations	17	12	14	-1.79	15	24	-5.05	8.25	12	16	0.32
Consolidated Net Income / (Loss)	17	12	14	-1.79	15	24	-5.05	8.25	12	16	0.32
Depreciation Expense	3.88	3.60	3.77	3.68	3.53	3.78	3.25	3.60	3.72	3.76	3.80
Amortization Expense	0.12	0.50	0.21	0.34	0.46	0.54	0.54	0.54	0.53	0.55	0.55
Non-Cash Adjustments To Reconcile Net Income	6.34	12	0.31	33	3.48	1.70	18	12	7.59	8.86	9.91
Changes in Operating Assets and Liabilities, net	-0.07	7.81	-14	-19	-49	20	-14	-17	-40	-6.04	-24
Net Cash From Investing Activities	-14	22	0.29	-28	12	-1.38	-1.27	0.11	-0.74	-0.29	-1.29
Net Cash From Continuing Investing Activities	-14	22	0.29	-28	12	-1.38	-1.27	0.11	-0.74	-0.29	-1.29
Purchase of Property, Plant & Equipment	-1.74	-1.43	-1.40	-1.31	-2.20	-1.43	-1.88	-1.09	-1.01	-1.07	-1.56
Acquisitions	-9.41	-	-	-	-2.75	-	-	-	0.00	-	-
Purchase of Investments	-3.44	-0.60	-14	-	-	-	-	-	-	-	-
Sale of Property, Plant & Equipment	0.03	0.02	0.04	0.13	0.03	-	0.04	0.03	0.06	0.21	-0.01
Sale and/or Maturity of Investments	0.10	24	15	11	17	0.05	0.57	1.17	0.21	0.57	0.29
Net Cash From Financing Activities	-8.78	-26	-6.01	-13	14	-25	0.98	5.00	6.91	-16	-0.87
Net Cash From Continuing Financing Activities	-8.78	-26	-6.01	-13	14	-25	0.98	5.00	6.91	-16	-0.87
Repurchase of Common Equity	-8.78	-1.01	-1.01	-3.00	-1.03	-5.05	-4.02	-	-3.09	-	-0.00
Issuance of Debt	0.00	-	-5.00	-10	15	-	5.00	5.00	10	-	15

This table presents Healthcare Services Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Total Assets	803	791	721	778	785	723	693	676
Total Current Assets	557	572	509	546	572	516	508	527
Cash & Equivalents	57	54	26	71	139	27	26	9.56
Restricted Cash	28	0.00	-	-	-	-	-	-
Short-Term Investments	51	93	95	114	125	91	76	73
Note & Lease Receivable	51	39	337	293	255	341	342	379
Accounts Receivable	331	345	-	-	-	-	-	-
Inventories, net	17	18	21	26	32	37	41	42
Prepaid Expenses	22	22	23	33	21	20	22	24
Plant, Property, & Equipment, net	28	29	23	28	0.00	0.00	13	14
Total Noncurrent Assets	218	190	189	203	213	207	172	135
Noncurrent Note & Lease Receivables	41	25	33	29	34	47	43	15
Goodwill	76	76	76	75	51	51	51	51
Intangible Assets	9.44	12	16	21	18	22	27	31
Noncurrent Deferred & Refundable Income Taxes	38	35	31	32	36	20	21	7.50
Employee Benefit Assets	50	41	33	47	47	37	29	29
Other Noncurrent Operating Assets	4.09	1.66	0.81	0.00	27	29	1.26	1.26
Total Liabilities & Shareholders' Equity	803	791	721	778	785	723	693	676
Total Liabilities	303	334	303	325	305	262	252	276
Total Current Liabilities	193	217	189	191	162	149	163	184
Short-Term Debt	0.00	25	25	0.00	-	-	-	-
Accounts Payable	81	83	68	64	52	54	61	74
Accrued Expenses	25	21	18	27	18	16	8.89	4.56
Current Deferred & Payable Income Tax Liabilities	8.39	7.20	0.00	-	-	8.08	7.14	15
Current Employee Benefit Liabilities	53	58	55	76	71	36	35	54
Other Current Liabilities	25	23	23	24	22	33	51	35
Total Noncurrent Liabilities	110	117	114	134	142	114	88	92
Capital Lease Obligations	8.03	11	8.10	11	11	-	-	-
Noncurrent Employee Benefit Liabilities	102	103	99	112	131	102	30	92
Other Noncurrent Operating Liabilities	0.39	2.99	6.14	10	0.00	12	-	-
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	500	457	418	453	480	460	441	400
Total Preferred & Common Equity	500	457	418	453	480	460	441	400
Total Common Equity	500	457	418	453	480	460	441	400
Common Stock	319	311	303	295	283	271	260	245
Retained Earnings	225	185	147	184	201	195	190	164
Treasury Stock	-41	-38	-28	-30	-8.96	-9.44	-9.66	-9.86
Accumulated Other Comprehensive Income / (Loss)	-2.32	-1.84	-3.48	4.00	5.56	2.92	0.16	0.84

This table presents Healthcare Services Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	823	806	800	804	751	762	719	722
Total Current Assets	575	578	573	580	533	549	510	513
Cash & Equivalents	64	27	26	29	31	29	16	20
Restricted Cash	29	26	25	25	-	-	-	-
Short-Term Investments	50	77	79	76	90	93	96	94
Note & Lease Receivable	49	406	399	407	368	380	351	347
Accounts Receivable	338	-	-	-	-	-	-	-
Inventories, net	17	17	18	18	19	20	20	23
Prepaid Expenses	27	25	26	26	24	26	25	24
Plant, Property, & Equipment, net	29	28	30	29	29	27	23	24
Total Noncurrent Assets	219	199	197	194	188	186	186	185
Noncurrent Note & Lease Receivables	36	23	21	23	29	31	32	27
Goodwill	80	76	76	76	76	76	76	76
Intangible Assets	10	10	11	11	13	14	15	17
Noncurrent Deferred & Refundable Income Taxes	40	36	39	35	33	28	28	34
Employee Benefit Assets	47	49	46	44	36	37	34	32
Other Noncurrent Operating Assets	6.09	5.61	4.51	4.30	1.81	0.71	0.76	-
Total Liabilities & Shareholders' Equity	823	806	800	804	751	762	719	722
Total Liabilities	309	317	328	329	309	311	279	300
Total Current Liabilities	199	197	209	209	188	190	162	182
Accounts Payable	79	77	72	73	71	66	64	67
Accrued Expenses	37	26	23	22	20	17	17	16
Current Deferred & Payable Income Tax Liabilities	9.60	4.50	4.28	12	1.27	1.36	-	-
Current Employee Benefit Liabilities	48	44	58	40	26	41	22	47
Other Current Liabilities	26	22	22	23	25	25	24	26
Total Noncurrent Liabilities	110	120	119	120	121	122	116	118
Capital Lease Obligations	7.95	9.03	11	11	12	12	8.59	8.75
Noncurrent Employee Benefit Liabilities	100	110	107	107	106	106	101	102
Other Noncurrent Operating Liabilities	2.04	0.43	0.72	2.27	3.12	3.85	6.45	8.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	514	489	471	475	442	451	441	422
Total Preferred & Common Equity	514	489	471	475	442	451	441	422
Total Common Equity	514	489	471	475	442	451	441	422
Common Stock	321	317	315	313	309	307	304	301
Retained Earnings	242	213	199	200	170	176	167	155
Treasury Stock	-47	-40	-39	-36	-33	-29	-29	-28
Accumulated Other Comprehensive Income / (Loss)	-1.81	-0.52	-2.62	-2.17	-4.78	-3.13	-2.27	-5.51

This table displays calculated financial ratios and metrics derived from Healthcare Services Group's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	2.65%	-1.11%	2.94%	-6.72%	-4.37%	-8.08%	7.60%	19.10%
EBITDA Growth	-5.19%	-8.57%	-5.24%	-44.19%	42.94%	-14.04%	-19.08%	5.59%
EBIT Growth	-6.14%	-9.43%	-7.82%	-50.98%	50.50%	-20.40%	-21.03%	5.21%
NOPAT Growth	-3.27%	-14.74%	-4.38%	-52.45%	51.48%	-27.74%	-0.50%	8.58%
Net Income Growth	2.83%	12.10%	-29.46%	-50.81%	52.80%	-22.68%	-5.33%	13.99%
EPS Growth	1.92%	13.04%	-29.23%	-50.76%	51.72%	-22.32%	-5.88%	13.33%
Operating Cash Flow Growth	-29.19%	632.61%	-122.01%	-82.92%	132.11%	16.93%	948.90%	-81.57%
Free Cash Flow Firm Growth	-64.75%	284.75%	-19.16%	-104.27%	269.92%	-8.81%	393.03%	-44.70%
Invested Capital Growth	7.76%	4.70%	18.33%	22.55%	-33.54%	1.14%	6.69%	28.28%
Revenue Q/Q Growth	0.82%	-0.01%	0.21%	-0.17%	-1.33%	-2.54%	0.02%	5.43%
EBITDA Q/Q Growth	-19.60%	21.31%	26.12%	-25.96%	4.37%	-12.93%	8.16%	0.04%
EBIT Q/Q Growth	-24.60%	30.85%	37.84%	-31.48%	5.03%	-16.32%	9.49%	-0.26%
NOPAT Q/Q Growth	-22.45%	24.43%	38.49%	-32.55%	7.35%	-22.52%	26.31%	-3.50%
Net Income Q/Q Growth	-22.70%	25.24%	47.24%	-32.11%	9.85%	-16.39%	15.75%	-0.13%
EPS Q/Q Growth	-24.29%	23.81%	53.33%	-32.29%	9.09%	-15.53%	14.29%	1.71%
Operating Cash Flow Q/Q Growth	-30.06%	156.69%	-2,676.34%	-54.41%	40.22%	9.14%	1.28%	15.19%
Free Cash Flow Firm Q/Q Growth	-75.43%	385.83%	72.63%	-114.43%	29.62%	-6.88%	37.23%	442.35%
Invested Capital Q/Q Growth	-5.24%	-8.40%	-3.66%	1.36%	-16.50%	-1.27%	2.64%	2.62%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	13.29%	12.85%	11.44%	14.04%	15.22%	12.38%	11.71%	13.47%
EBITDA Margin	3.56%	3.86%	4.17%	4.53%	7.57%	5.07%	5.42%	7.20%
Operating Margin	2.62%	2.87%	3.13%	3.50%	6.66%	4.23%	4.89%	6.66%
EBIT Margin	2.62%	2.87%	3.13%	3.50%	6.66%	4.23%	4.89%	6.66%
Profit (Net Income) Margin	2.30%	2.30%	2.03%	2.96%	5.61%	3.51%	4.17%	4.74%
Tax Burden Percent	74.56%	72.35%	76.86%	74.10%	76.39%	75.89%	83.60%	66.35%
Interest Burden Percent	117.57%	110.59%	84.11%	114.02%	110.22%	109.27%	102.12%	107.33%
Effective Tax Rate	25.44%	27.65%	23.14%	25.90%	23.61%	24.11%	16.40%	33.65%
Return on Invested Capital (ROIC)	9.36%	10.28%	13.38%	16.82%	31.43%	17.37%	24.95%	29.13%
ROIC Less NNEP Spread (ROIC-NNEP)	4.42%	6.60%	18.31%	14.02%	26.50%	12.40%	23.08%	22.22%
Return on Net Nonoperating Assets (RNNOA)	-1.10%	-1.50%	-5.51%	-6.42%	-10.45%	-3.03%	-5.08%	-5.24%
Return on Equity (ROE)	8.25%	8.78%	7.86%	10.40%	20.98%	14.33%	19.87%	23.88%
Cash Return on Invested Capital (CROIC)	1.89%	5.69%	-3.42%	-3.45%	71.72%	16.23%	18.48%	4.35%
Operating Return on Assets (OROA)	5.65%	6.35%	7.07%	7.35%	15.55%	11.01%	14.30%	20.57%
Return on Assets (ROA)	4.95%	5.08%	4.57%	6.21%	13.09%	9.13%	12.21%	14.65%
Return on Common Equity (ROCE)	8.25%	8.78%	7.86%	10.40%	20.98%	14.33%	19.87%	23.88%
Return on Equity Simple (ROE_SIMPLE)	7.90%	8.41%	8.19%	10.72%	20.54%	14.03%	18.95%	22.06%
Net Operating Profit after Tax (NOPAT)	34	35	41	43	90	59	82	82
NOPAT Margin	1.96%	2.08%	2.41%	2.59%	5.09%	3.21%	4.08%	4.42%
Net Nonoperating Expense Percent (NNEP)	4.94%	3.68%	-4.93%	2.80%	4.93%	4.97%	1.87%	6.91%
Return On Investment Capital (ROIC_SIMPLE)	6.61%	7.04%	9.02%	-	-	-	-	-
Cost of Revenue to Revenue	86.71%	87.15%	88.56%	85.96%	84.78%	87.62%	88.29%	86.53%
SG&A Expenses to Revenue	10.67%	9.98%	8.30%	10.54%	8.57%	8.15%	6.82%	6.81%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	10.67%	9.98%	8.30%	10.54%	8.57%	8.15%	6.82%	6.81%
Earnings before Interest and Taxes (EBIT)	45	48	53	57	117	78	98	124
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	61	64	71	74	133	93	108	134
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.70	1.68	2.13	2.77	3.98	3.46	5.78	8.16
Price to Tangible Book Value (P/TBV)	2.05	2.08	2.72	3.51	4.65	4.12	7.02	10.26
Price to Revenue (P/Rev)	0.50	0.46	0.53	0.76	1.09	0.87	1.27	1.75
Price to Earnings (P/E)	21.83	19.14	33.22	26.69	19.39	24.68	30.53	36.97
Dividend Yield	0.00%	0.00%	7.11%	4.95%	3.16%	3.69%	2.24%	1.69%
Earnings Yield	4.58%	5.23%	3.01%	3.75%	5.16%	4.05%	3.28%	2.70%
Enterprise Value to Invested Capital (EV/IC)	1.94	1.90	2.43	3.87	7.30	4.31	7.23	10.02
Enterprise Value to Revenue (EV/Rev)	0.42	0.39	0.47	0.66	0.94	0.80	1.22	1.71
Enterprise Value to EBITDA (EV/EBITDA)	11.84	10.15	11.36	14.51	12.45	15.83	22.56	23.72
Enterprise Value to EBIT (EV/EBIT)	16.07	13.64	15.12	18.79	14.16	18.95	25.02	25.66
Enterprise Value to NOPAT (EV/NOPAT)	21.55	18.86	19.67	25.36	18.54	24.97	29.92	38.68
Enterprise Value to Operating Cash Flow (EV/OCF)	23.49	15.05	0.00	29.10	7.64	15.77	30.58	416.70
Enterprise Value to Free Cash Flow (EV/FCFF)	106.81	34.06	0.00	0.00	8.12	26.72	40.41	258.79
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.02	0.08	0.08	0.03	0.02	0.00	0.00	0.00
Long-Term Debt to Equity	0.02	0.02	0.02	0.03	0.02	0.00	0.00	0.00
Financial Leverage	-0.25	-0.23	-0.30	-0.46	-0.39	-0.24	-0.22	-0.24
Leverage Ratio	1.67	1.73	1.72	1.67	1.60	1.57	1.63	1.63
Compound Leverage Factor	1.96	1.91	1.45	1.91	1.77	1.72	1.66	1.75
Debt to Total Capital	1.58%	7.35%	7.33%	2.44%	2.31%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	5.07%	5.54%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	1.58%	2.28%	1.79%	2.44%	2.31%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	98.42%	92.65%	92.67%	97.56%	97.69%	100.00%	100.00%	100.00%
Debt to EBITDA	0.13	0.56	0.47	0.15	0.09	0.00	0.00	0.00
Net Debt to EBITDA	-2.09	-1.73	-1.25	-2.34	-1.90	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.13	0.17	0.11	0.15	0.09	0.00	0.00	0.00
Debt to NOPAT	0.24	1.04	0.81	0.27	0.13	0.00	0.00	0.00
Net Debt to NOPAT	-3.80	-3.20	-2.17	-4.08	-2.83	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.24	0.32	0.20	0.27	0.13	0.00	0.00	0.00
Altman Z-Score	4.94	4.56	5.17	5.55	7.49	7.54	10.41	11.40
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	2.89	2.64	2.69	2.86	3.53	3.47	3.11	2.86
Quick Ratio	2.54	2.45	2.42	2.50	3.20	3.09	2.72	2.51
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	6.77	19	-10	-8.73	204	55	61	12
Operating Cash Flow to CapEx	502.89%	823.05%	-169.55%	677.65%	5,340.87%	2,244.69%	1,861.19%	150.82%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.01
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.60
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.89
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	2.15	2.21	2.26	2.10	2.34	2.60	2.93	3.09
Accounts Receivable Turnover	5.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	84.46	73.49	63.45	49.01	43.83	41.38	42.18	40.17
Fixed Asset Turnover	60.23	64.60	66.18	0.00	0.00	0.00	151.66	138.05
Accounts Payable Turnover	18.10	19.23	22.56	24.20	27.98	27.84	26.02	27.44
Days Sales Outstanding (DSO)	71.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	4.32	4.97	5.75	7.45	8.33	8.82	8.65	9.09
Days Payable Outstanding (DPO)	20.17	18.98	16.18	15.08	13.04	13.11	14.03	13.30
Cash Conversion Cycle (CCC)	56.04	-14.02	-10.43	-7.64	-4.71	-4.29	-5.38	-4.21
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	372	345	330	279	227	342	338	317
Invested Capital Turnover	4.78	4.95	5.55	6.49	6.18	5.41	6.11	6.60
Increase / (Decrease) in Invested Capital	27	15	51	51	-115	3.87	21	70
Enterprise Value (EV)	724	655	801	1,080	1,660	1,476	2,447	3,179
Market Capitalization	851	766	889	1,254	1,913	1,594	2,550	3,262
Book Value per Share	$6.82	$6.18	$5.65	$6.07	$6.46	$6.21	$5.97	$5.46
Tangible Book Value per Share	$5.66	$5.00	$4.41	$4.79	$5.53	$5.22	$4.92	$4.34
Total Capital	508	493	451	464	492	460	441	400
Total Debt	8.03	36	33	11	11	0.00	0.00	0.00
Total Long-Term Debt	8.03	11	8.10	11	11	0.00	0.00	0.00
Net Debt	-128	-111	-88	-174	-253	-118	-102	-83
Capital Expenditures (CapEx)	6.13	5.29	4.82	5.48	4.07	4.17	4.30	5.06
Debt-free, Cash-free Net Working Capital (DFCFNWC)	228	232	223	170	146	249	242	260
Debt-free Net Working Capital (DFNWC)	364	380	345	355	410	367	345	343
Net Working Capital (NWC)	364	355	320	355	410	367	345	343
Net Nonoperating Expense (NNE)	-5.90	-3.68	6.47	-5.97	-9.15	-5.48	-1.73	-6.03
Net Nonoperating Obligations (NNO)	-128	-111	-88	-174	-253	-118	-102	-83
Total Depreciation and Amortization (D&A)	16	16	18	17	16	15	11	10
Debt-free, Cash-free Net Working Capital to Revenue	13.31%	13.90%	13.20%	10.36%	8.28%	13.53%	12.10%	14.00%
Debt-free Net Working Capital to Revenue	21.22%	22.72%	20.39%	21.64%	23.30%	19.94%	17.21%	18.44%
Net Working Capital to Revenue	21.22%	21.23%	18.91%	21.64%	23.30%	19.94%	17.21%	18.44%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.54	$0.52	$0.47	$0.61	$1.32	$0.87	$1.13	$1.20
Adjusted Weighted Average Basic Shares Outstanding	73.75M	74.29M	74.34M	74.82M	74.70M	74.36M	74.00M	73.36M
Adjusted Diluted Earnings per Share	$0.53	$0.52	$0.47	$0.61	$1.32	$0.87	$1.12	$1.19
Adjusted Weighted Average Diluted Shares Outstanding	73.99M	74.34M	74.35M	74.96M	74.79M	74.59M	74.61M	74.35M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	73.49M	73.58M	74.39M	74.00M	74.72M	74.40M	74.04M	73.68M
Normalized Net Operating Profit after Tax (NOPAT)	34	35	41	43	90	59	82	82
Normalized NOPAT Margin	1.96%	2.08%	2.41%	2.59%	5.09%	3.21%	4.08%	4.42%
Pre Tax Income Margin	3.09%	3.17%	2.64%	3.99%	7.34%	4.62%	4.99%	7.14%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	90.89
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	60.31
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	87.18
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	56.60
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	185.07%	128.19%	61.52%	91.28%	68.48%	62.62%
Augmented Payout Ratio	15.32%	31.66%	188.20%	175.45%	62.20%	92.19%	68.82%	62.62%

This table displays calculated financial ratios and metrics derived from Healthcare Services Group's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	5.72%	3.30%	4.07%	1.76%	1.49%	-0.04%	-0.75%	-1.39%	-2.24%	0.85%	-0.27%
EBITDA Growth	24.99%	-45.45%	2,635.48%	-91.63%	13.35%	52.76%	-113.19%	-34.11%	-15.38%	212.95%	-62.25%
EBIT Growth	30.63%	-51.60%	459.76%	-131.09%	18.96%	65.92%	-356.56%	-42.63%	-16.89%	555.85%	-85.06%
NOPAT Growth	31.13%	-46.45%	483.38%	-128.83%	18.27%	49.52%	-653.84%	-47.61%	-16.37%	495.10%	-93.84%
Net Income Growth	12.54%	-49.29%	377.99%	-121.66%	31.17%	49.05%	-1,667.39%	21.03%	3.02%	229.61%	-96.62%
EPS Growth	9.52%	-53.13%	371.43%	-118.18%	31.25%	45.45%	0.00%	22.22%	6.67%	266.67%	-100.00%
Operating Cash Flow Growth	205.64%	-26.78%	46.67%	120.44%	-59.81%	115.98%	129.71%	-17.91%	46.03%	-27.04%	57.18%
Free Cash Flow Firm Growth	411.36%	-400.56%	91.05%	93.06%	68.10%	114.03%	43.38%	42.08%	51.66%	23.93%	-1,079.32%
Invested Capital Growth	-4.39%	7.76%	4.17%	0.28%	6.33%	4.70%	10.11%	15.76%	13.71%	18.33%	24.51%
Revenue Q/Q Growth	2.25%	2.26%	0.44%	0.67%	-0.10%	3.03%	-1.80%	0.41%	-1.60%	2.30%	-2.44%
EBITDA Q/Q Growth	50.99%	-12.82%	1,724.91%	-94.80%	-35.32%	4,152.04%	-106.02%	-29.51%	-11.19%	249.84%	-69.91%
EBIT Q/Q Growth	66.96%	-16.65%	671.81%	-116.42%	-39.45%	719.52%	-149.42%	-37.19%	-13.71%	857.96%	-88.95%
NOPAT Q/Q Growth	49.51%	-10.04%	709.35%	-116.00%	-40.24%	744.13%	-145.83%	-34.37%	-22.82%	2,285.87%	-95.66%
Net Income Q/Q Growth	44.53%	-15.04%	884.68%	-111.68%	-36.09%	565.78%	-161.15%	-29.28%	-26.00%	4,798.14%	-95.28%
EPS Q/Q Growth	53.33%	-21.05%	1,050.00%	-109.52%	-34.38%	557.14%	-163.64%	-31.25%	-27.27%	0.00%	-100.00%
Operating Cash Flow Q/Q Growth	-24.04%	739.61%	-73.58%	162.69%	-152.65%	1,581.80%	-60.29%	145.45%	-171.16%	331.34%	-209.74%
Free Cash Flow Firm Q/Q Growth	316.11%	-364.02%	-9.05%	71.53%	-292.16%	113.81%	15.46%	-30.97%	8.28%	44.25%	13.51%
Invested Capital Q/Q Growth	1.62%	-5.24%	2.99%	-3.59%	14.53%	-8.40%	-0.85%	2.23%	12.77%	-3.66%	4.23%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	15.18%	13.39%	14.81%	9.75%	15.24%	17.63%	8.37%	12.11%	13.15%	13.37%	9.07%
EBITDA Margin	6.03%	4.08%	4.79%	0.26%	5.10%	7.73%	-0.20%	3.21%	4.57%	5.06%	1.48%
Operating Margin	5.14%	3.15%	3.86%	-0.68%	4.16%	6.72%	-1.12%	2.22%	3.55%	4.05%	0.43%
EBIT Margin	5.14%	3.15%	3.86%	-0.68%	4.16%	6.72%	-1.12%	2.22%	3.55%	4.05%	0.43%
Profit (Net Income) Margin	3.85%	2.72%	3.28%	-0.42%	3.62%	5.55%	-1.23%	1.97%	2.80%	3.72%	0.08%
Tax Burden Percent	72.10%	80.51%	74.60%	90.03%	71.83%	72.78%	79.69%	75.49%	72.24%	80.76%	32.43%
Interest Burden Percent	103.86%	107.45%	113.77%	68.70%	121.03%	113.46%	137.82%	117.60%	109.13%	113.83%	55.44%
Effective Tax Rate	27.90%	19.49%	25.40%	0.00%	28.17%	27.22%	0.00%	24.51%	27.76%	19.24%	67.57%
Return on Invested Capital (ROIC)	16.66%	12.12%	12.73%	-2.10%	13.06%	24.20%	-3.63%	7.92%	12.32%	18.15%	0.77%
ROIC Less NNEP Spread (ROIC-NNEP)	16.07%	11.43%	10.62%	-2.39%	9.45%	21.40%	-1.10%	6.54%	11.28%	16.69%	0.95%
Return on Net Nonoperating Assets (RNNOA)	-3.49%	-2.85%	-1.83%	0.42%	-1.52%	-4.88%	0.18%	-1.32%	-2.39%	-5.03%	-0.30%
Return on Equity (ROE)	13.17%	9.26%	10.90%	-1.68%	11.53%	19.31%	-3.45%	6.59%	9.93%	13.12%	0.47%
Cash Return on Invested Capital (CROIC)	14.20%	1.89%	7.16%	6.87%	3.42%	5.69%	-1.87%	-5.42%	-1.83%	-3.42%	-12.31%
Operating Return on Assets (OROA)	10.99%	6.78%	8.44%	-1.46%	9.16%	14.85%	-2.54%	4.95%	8.14%	9.13%	0.96%
Return on Assets (ROA)	8.23%	5.86%	7.17%	-0.91%	7.96%	12.27%	-2.78%	4.39%	6.42%	8.39%	0.17%
Return on Common Equity (ROCE)	13.17%	9.26%	10.90%	-1.68%	11.53%	19.31%	-3.45%	6.59%	9.93%	13.12%	0.47%
Return on Equity Simple (ROE_SIMPLE)	8.05%	0.00%	10.45%	6.78%	8.86%	0.00%	6.94%	7.99%	7.85%	0.00%	5.51%
Net Operating Profit after Tax (NOPAT)	17	11	12	-2.02	13	21	-3.22	7.02	11	14	0.58
NOPAT Margin	3.71%	2.53%	2.88%	-0.47%	2.99%	4.89%	-0.78%	1.68%	2.56%	3.27%	0.14%
Net Nonoperating Expense Percent (NNEP)	0.60%	0.69%	2.11%	0.29%	3.60%	2.80%	-2.54%	1.38%	1.04%	1.46%	-0.18%
Return On Investment Capital (ROIC_SIMPLE)	3.18%	2.18%	-	-	-	4.20%	-	-	-	3.07%	-
Cost of Revenue to Revenue	84.82%	86.61%	85.19%	90.25%	84.76%	82.37%	91.63%	87.89%	86.85%	86.63%	90.93%
SG&A Expenses to Revenue	10.04%	10.24%	10.95%	10.42%	11.08%	10.91%	9.49%	9.89%	9.60%	9.32%	8.64%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	10.04%	10.24%	10.95%	10.42%	11.08%	10.91%	9.49%	9.89%	9.60%	9.32%	8.64%
Earnings before Interest and Taxes (EBIT)	23	14	17	-2.89	18	28	-4.60	9.30	15	17	1.79
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	27	18	21	1.12	22	33	-0.81	13	19	21	6.13
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.44	1.70	1.68	1.65	1.94	1.68	1.75	2.46	2.34	2.13	2.09
Price to Tangible Book Value (P/TBV)	1.75	2.05	2.03	2.02	2.38	2.08	2.19	3.06	2.95	2.72	2.68
Price to Revenue (P/Rev)	0.43	0.50	0.48	0.46	0.55	0.46	0.46	0.66	0.61	0.53	0.52
Price to Earnings (P/E)	17.74	21.83	14.82	23.98	21.88	19.14	32.02	38.34	36.44	33.22	45.43
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	8.17%	5.71%	6.15%	7.11%	7.12%
Earnings Yield	5.64%	4.58%	6.75%	4.17%	4.57%	5.23%	3.12%	2.61%	2.74%	3.01%	2.20%
Enterprise Value to Invested Capital (EV/IC)	1.60	1.94	1.84	1.81	2.13	1.90	1.88	2.73	2.59	2.43	2.34
Enterprise Value to Revenue (EV/Rev)	0.35	0.42	0.43	0.41	0.50	0.39	0.42	0.62	0.57	0.47	0.48
Enterprise Value to EBITDA (EV/EBITDA)	9.09	11.84	9.52	12.60	12.58	10.15	13.35	17.27	14.37	11.36	14.34
Enterprise Value to EBIT (EV/EBIT)	11.99	16.07	12.12	17.86	16.59	13.64	19.34	24.10	19.28	15.12	20.87
Enterprise Value to NOPAT (EV/NOPAT)	16.09	21.55	16.72	25.29	22.99	18.86	25.42	31.85	25.05	19.67	27.28
Enterprise Value to Operating Cash Flow (EV/OCF)	7.17	23.49	16.43	16.15	24.96	15.05	41.85	252.42	168.25	0.00	2,529.34
Enterprise Value to Free Cash Flow (EV/FCFF)	11.01	106.81	26.25	26.33	64.29	34.06	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.02	0.02	0.07	0.09	0.11	0.08	0.13	0.11	0.10	0.08	0.08
Long-Term Debt to Equity	0.02	0.02	0.02	0.02	0.02	0.02	0.03	0.03	0.02	0.02	0.02
Financial Leverage	-0.22	-0.25	-0.17	-0.17	-0.16	-0.23	-0.17	-0.20	-0.21	-0.30	-0.32
Leverage Ratio	1.65	1.67	1.67	1.69	1.66	1.73	1.71	1.69	1.65	1.72	1.68
Compound Leverage Factor	1.71	1.79	1.90	1.16	2.01	1.96	2.35	1.99	1.80	1.96	0.93
Debt to Total Capital	1.52%	1.58%	6.51%	7.94%	9.63%	7.35%	11.37%	10.27%	9.00%	7.33%	7.40%
Short-Term Debt to Total Capital	0.00%	0.00%	4.78%	5.86%	7.62%	5.07%	9.03%	7.97%	7.23%	5.54%	5.48%
Long-Term Debt to Total Capital	1.52%	1.58%	1.73%	2.08%	2.02%	2.28%	2.34%	2.30%	1.77%	1.79%	1.92%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	98.48%	98.42%	93.49%	92.06%	90.37%	92.65%	88.63%	89.73%	91.00%	92.67%	92.60%
Debt to EBITDA	0.12	0.13	0.45	0.74	0.76	0.56	1.07	0.86	0.65	0.47	0.60
Net Debt to EBITDA	-2.04	-2.09	-1.26	-1.65	-1.18	-1.73	-1.22	-1.17	-1.02	-1.25	-1.42
Long-Term Debt to EBITDA	0.12	0.13	0.12	0.19	0.16	0.17	0.22	0.19	0.13	0.11	0.16
Debt to NOPAT	0.21	0.24	0.79	1.49	1.38	1.04	2.03	1.58	1.13	0.81	1.15
Net Debt to NOPAT	-3.62	-3.80	-2.22	-3.30	-2.16	-3.20	-2.32	-2.16	-1.78	-2.17	-2.71
Long-Term Debt to NOPAT	0.21	0.24	0.21	0.39	0.29	0.32	0.42	0.35	0.22	0.20	0.30
Altman Z-Score	4.61	4.82	4.67	4.41	4.74	4.47	4.58	5.26	5.53	5.00	4.96
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.89	2.89	2.93	2.74	2.77	2.64	2.84	2.90	3.15	2.69	2.82
Quick Ratio	2.52	2.54	2.59	2.41	2.45	2.45	2.60	2.65	2.85	2.42	2.53
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	34	-16	-3.38	-3.10	-11	5.23	-38	-45	-34	-37	-67
Operating Cash Flow to CapEx	1,601.69%	2,569.48%	317.99%	1,374.81%	-1,198.02%	3,450.45%	159.78%	699.06%	-1,709.34%	2,655.80%	-627.92%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.14	2.15	2.19	2.16	2.20	2.21	2.27	2.23	2.29	2.26	2.23
Accounts Receivable Turnover	0.00	5.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	85.42	84.46	80.45	77.69	75.94	73.49	70.40	67.79	65.97	63.45	60.82
Fixed Asset Turnover	59.49	60.23	59.11	59.36	63.80	64.60	62.62	63.72	67.09	66.18	0.00
Accounts Payable Turnover	19.89	18.10	19.80	21.32	21.17	19.23	21.37	22.33	23.15	22.56	25.48
Days Sales Outstanding (DSO)	0.00	71.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	4.27	4.32	4.54	4.70	4.81	4.97	5.18	5.38	5.53	5.75	6.00
Days Payable Outstanding (DPO)	18.35	20.17	18.43	17.12	17.24	18.98	17.08	16.35	15.77	16.18	14.32
Cash Conversion Cycle (CCC)	-14.08	56.04	-13.90	-12.42	-12.43	-14.02	-11.90	-10.96	-10.24	-10.43	-8.32
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	378	372	393	381	396	345	377	380	372	330	342
Invested Capital Turnover	4.50	4.78	4.42	4.42	4.37	4.95	4.65	4.73	4.81	5.55	5.46
Increase / (Decrease) in Invested Capital	-17	27	16	1.08	24	15	35	52	45	51	67
Enterprise Value (EV)	605	724	724	689	843	655	709	1,037	963	801	802
Market Capitalization	741	851	820	779	922	766	774	1,108	1,032	889	881
Book Value per Share	$7.00	$6.82	$6.66	$6.40	$6.42	$6.18	$5.95	$6.07	$5.92	$5.65	$5.70
Tangible Book Value per Share	$5.77	$5.66	$5.49	$5.23	$5.24	$5.00	$4.76	$4.87	$4.71	$4.41	$4.45
Total Capital	522	508	523	512	525	493	498	502	484	451	456
Total Debt	7.95	8.03	34	41	51	36	57	52	44	33	34
Total Long-Term Debt	7.95	8.03	9.03	11	11	11	12	12	8.59	8.10	8.75
Net Debt	-136	-128	-96	-90	-79	-111	-65	-70	-69	-88	-80
Capital Expenditures (CapEx)	1.72	1.41	1.36	1.19	2.17	1.43	1.84	1.06	0.95	0.86	1.58
Debt-free, Cash-free Net Working Capital (DFCFNWC)	232	228	276	263	281	232	269	278	271	223	242
Debt-free Net Working Capital (DFNWC)	376	364	406	394	411	380	391	399	383	345	356
Net Working Capital (NWC)	376	364	381	364	371	355	346	359	348	320	331
Net Nonoperating Expense (NNE)	-0.64	-0.83	-1.70	-0.24	-2.66	-2.79	1.83	-1.24	-0.98	-1.92	0.26
Net Nonoperating Obligations (NNO)	-136	-128	-96	-90	-79	-111	-65	-70	-69	-88	-80
Total Depreciation and Amortization (D&A)	4.00	4.10	3.98	4.02	3.99	4.31	3.79	4.14	4.25	4.30	4.34
Debt-free, Cash-free Net Working Capital to Revenue	13.35%	13.31%	16.21%	15.61%	16.78%	13.90%	16.11%	16.57%	16.11%	13.20%	14.38%
Debt-free Net Working Capital to Revenue	21.62%	21.22%	23.85%	23.37%	24.50%	22.72%	23.37%	23.85%	22.79%	20.39%	21.10%
Net Working Capital to Revenue	21.62%	21.22%	22.38%	21.59%	22.12%	21.23%	20.67%	21.46%	20.70%	18.91%	19.62%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.23	$0.16	$0.19	($0.02)	$0.21	$0.32	($0.07)	$0.12	$0.17	$0.22	$0.00
Adjusted Weighted Average Basic Shares Outstanding	73.67M	73.75M	73.69M	73.85M	73.93M	74.29M	74.36M	74.48M	74.50M	74.34M	74.34M
Adjusted Diluted Earnings per Share	$0.23	$0.15	$0.19	($0.02)	$0.21	$0.32	($0.07)	$0.12	$0.17	$0.22	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	73.96M	73.99M	73.93M	73.85M	74.06M	74.34M	74.36M	74.57M	74.52M	74.35M	74.35M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	72.92M	73.49M	73.29M	73.38M	73.65M	73.58M	73.85M	74.20M	74.20M	74.39M	74.09M
Normalized Net Operating Profit after Tax (NOPAT)	17	11	12	-2.02	13	21	-3.22	7.02	11	14	1.25
Normalized NOPAT Margin	3.71%	2.53%	2.88%	-0.47%	2.99%	4.89%	-0.78%	1.68%	2.56%	3.27%	0.30%
Pre Tax Income Margin	5.34%	3.38%	4.39%	-0.47%	5.03%	7.62%	-1.54%	2.61%	3.87%	4.61%	0.24%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	185.07%	270.65%
Augmented Payout Ratio	33.34%	15.32%	19.75%	40.93%	24.01%	31.66%	23.19%	8.59%	8.95%	188.20%	344.69%

Frequently Asked Questions About Healthcare Services Group's Financials

When does Healthcare Services Group's financial year end?

According to the most recent income statement we have on file, Healthcare Services Group's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Healthcare Services Group's net income changed over the last 7 years?

Healthcare Services Group's net income appears to be on a downward trend, with a most recent value of $39.47 million in 2024, falling from $88.23 million in 2017. The previous period was $38.39 million in 2023. See where experts think Healthcare Services Group is headed by visiting Healthcare Services Group's forecast page.

What is Healthcare Services Group's operating income?

Healthcare Services Group's total operating income in 2024 was $45.03 million, based on the following breakdown:

Total Gross Profit: $228.09 million
Total Operating Expenses: $183.06 million

How has Healthcare Services Group revenue changed over the last 7 years?

Over the last 7 years, Healthcare Services Group's total revenue changed from $1.86 billion in 2017 to $1.72 billion in 2024, a change of -7.8%.

How much debt does Healthcare Services Group have?

Healthcare Services Group's total liabilities were at $302.85 million at the end of 2024, a 9.3% decrease from 2023, and a 9.7% increase since 2017.

How much cash does Healthcare Services Group have?

In the past 7 years, Healthcare Services Group's cash and equivalents has ranged from $9.56 million in 2017 to $139.33 million in 2020, and is currently $56.78 million as of their latest financial filing in 2024.

How has Healthcare Services Group's book value per share changed over the last 7 years?

Over the last 7 years, Healthcare Services Group's book value per share changed from 5.46 in 2017 to 6.82 in 2024, a change of 25.0%.

Related Companies

This page (NASDAQ:HCSG) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Healthcare Services Group (HCSG) Financials

Frequently Asked Questions About Healthcare Services Group's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Healthcare Services Group (HCSG) Financials

Annual Income Statements for Healthcare Services Group

Quarterly Income Statements for Healthcare Services Group

Annual Cash Flow Statements for Healthcare Services Group

Quarterly Cash Flow Statements for Healthcare Services Group

Annual Balance Sheets for Healthcare Services Group

Quarterly Balance Sheets for Healthcare Services Group

Annual Metrics And Ratios for Healthcare Services Group

Quarterly Metrics And Ratios for Healthcare Services Group

Frequently Asked Questions About Healthcare Services Group's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools